Ritalin and Metastases to spine - a phase IV clinical study of FDA data
Summary:
Metastases to spine is reported as a side effect among people who take Ritalin (methylphenidate hydrochloride), especially for people who are male, 50-59 old, also take Zometa, and have Metastases to bone.
The phase IV clinical study analyzes which people have Metastases to spine when taking Ritalin. It is created by eHealthMe based on reports of 26,179 people who have side effects when taking Ritalin from the FDA, and is updated regularly.
What is Ritalin?
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.
What is Metastases to spine?
Metastases to spine (cancer spreads to spine) is found to be associated with 645 drugs and 484 conditions by eHealthMe. Check the latest studies of Metastases to spine.
26,179 people reported to have side effects when taking Ritalin.
Among them, 46 people (0.18%) have Metastases to spine.

Among these 46 people:
What is the gender of people who have Metastases to spine when taking Ritalin? *
- female: 43.48 %
- male: 56.52 %
What is the age of people who have Metastases to spine when taking Ritalin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 55.88 %
- 60+: 44.12 %
What are other drugs people take besides Ritalin? *
- Zometa: 42 people, 91.30%
- Zofran: 38 people, 82.61%
- Dexamethasone: 37 people, 80.43%
- Lorazepam: 30 people, 65.22%
- Ms Contin: 25 people, 54.35%
- Ambien: 25 people, 54.35%
- Protonix: 25 people, 54.35%
- Compazine: 24 people, 52.17%
- Neurontin: 24 people, 52.17%
- Zoloft: 23 people, 50.00%
What are other side effects people have besides Metastases to spine? *
- Stress And Anxiety: 41 people, 89.13%
- Osteonecrosis Of Jaw (death of bone of jaw): 38 people, 82.61%
- Metastases To Bone (cancer spreads to bone): 37 people, 80.43%
- Pain: 35 people, 76.09%
- High Blood Pressure: 35 people, 76.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 32 people, 69.57%
- Injury: 32 people, 69.57%
- Headache (pain in head): 28 people, 60.87%
- Cellulitis (infection under the skin): 28 people, 60.87%
- Bone Pain: 28 people, 60.87%
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 17 people, 36.96%
- Pain: 10 people, 21.74%
- Insomnia (sleeplessness): 9 people, 19.57%
- Prostate Cancer: 8 people, 17.39%
- Neoplasm Malignant (cancer tumour): 8 people, 17.39%
- Osteoporosis (bones weak and more likely to break): 8 people, 17.39%
- Multiple Myeloma (cancer of the plasma cells): 7 people, 15.22%
- Fatigue (feeling of tiredness): 3 people, 6.52%
- Breast Cancer Metastatic: 2 people, 4.35%
- Cardiac Failure Chronic: 1 person, 2.17%
* Approximation only. Some reports may have incomplete information.
Do you take Ritalin and have Metastases to spine?
- Check whether Metastases to spine is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ritalin:
- Ritalin (29,427 reports)
Metastases to spine treatments and more:
- Metastases to spine (5,403 reports)
How severe was Metastases to spine and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Metastases to spine:
- Metastases to spine (645 drugs)
Browse all the conditions that are associated with Metastases to spine:
- Metastases to spine (484 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin) and Ritalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Feverfew vs. Verapamil Hydrochloride, side effect and effectiveness comparison - a second ago
- Could Citric Acid cause Rashes? - 7 seconds ago
- Vicodin vs. Hydrocodone Compound, side effect and effectiveness comparison - 7 seconds ago
- Could Fish Oil cause Affective Disorder? - 12 seconds ago
- Garlic vs. Vitamins, side effect and effectiveness comparison - 17 seconds ago
- Escitalopram vs. Paxil, side effect and effectiveness comparison - 17 seconds ago
- Could Nitroglycerin cause Haemoglobin Decreased? - 20 seconds ago
- Drug interactions of Xarelto and Anoro Ellipta - 24 seconds ago
- Drug interactions of Irbesartan and Levothroid - 26 seconds ago
- Could Alendronate Sodium cause Vaginitis Bacterial? - 45 seconds ago